1. ZHAW digitalcollection
  2. Life Sciences und Facility Management
  3. Publikationen
  4. Publikationen Life Sciences und Facility Management
Please use this identifier to cite or link to this item: https://doi.org/10.21256/zhaw-21844
Full metadata record
DC FieldValueLanguage
dc.contributor.authorZizzari, Alessandra Tania-
dc.contributor.authorPliatsika, Dimanthi-
dc.contributor.authorGall, Flavio-
dc.contributor.authorFischer, Thomas-
dc.contributor.authorRiedl, Rainer-
dc.date.accessioned2021-02-25T09:48:25Z-
dc.date.available2021-02-25T09:48:25Z-
dc.date.issued2021-01-23-
dc.identifier.issn1878-5832de_CH
dc.identifier.urihttps://digitalcollection.zhaw.ch/handle/11475/21844-
dc.description.abstractOwing to their structural diversity, peptides are a unique source of innovative active ingredients. However, their development has been challenging because of their disadvantageous pharmacokinetic (PK) properties. Over the past decade, many attempts have been made to improve the oral bioavailability of peptide drugs. In this review, we highlight the most recent and promising techniques aimed at the improvement of the oral bioavailability of peptides. The most recent findings will influence future approaches of pharmaceutical companies in the development of new, more efficient, and safer orally delivered peptides.de_CH
dc.language.isoende_CH
dc.publisherElsevierde_CH
dc.relation.ispartofDrug Discovery Todayde_CH
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/4.0/de_CH
dc.subject.ddc615: Pharmakologie und Therapeutikde_CH
dc.titleNew perspectives in oral peptide deliveryde_CH
dc.typeBeitrag in wissenschaftlicher Zeitschriftde_CH
dcterms.typeTextde_CH
zhaw.departementLife Sciences und Facility Managementde_CH
zhaw.organisationalunitInstitut für Chemie und Biotechnologie (ICBT)de_CH
dc.identifier.doi10.1016/j.drudis.2021.01.020de_CH
dc.identifier.doi10.21256/zhaw-21844-
dc.identifier.pmid33497830de_CH
zhaw.funding.euNode_CH
zhaw.issue4de_CH
zhaw.originated.zhawYesde_CH
zhaw.pages.end1105de_CH
zhaw.pages.start1097de_CH
zhaw.publication.statuspublishedVersionde_CH
zhaw.volume26de_CH
zhaw.publication.reviewPeer review (Publikation)de_CH
zhaw.webfeedCC Drug Discoveryde_CH
zhaw.author.additionalNode_CH
zhaw.display.portraitYesde_CH
Appears in collections:Publikationen Life Sciences und Facility Management

Files in This Item:
File Description SizeFormat 
2021_Zizzari-et-al_New-perspectives-in-oral-peptide-delivery.pdf1.56 MBAdobe PDFThumbnail
View/Open
Show simple item record
Zizzari, A. T., Pliatsika, D., Gall, F., Fischer, T., & Riedl, R. (2021). New perspectives in oral peptide delivery. Drug Discovery Today, 26(4), 1097–1105. https://doi.org/10.1016/j.drudis.2021.01.020
Zizzari, A.T. et al. (2021) ‘New perspectives in oral peptide delivery’, Drug Discovery Today, 26(4), pp. 1097–1105. Available at: https://doi.org/10.1016/j.drudis.2021.01.020.
A. T. Zizzari, D. Pliatsika, F. Gall, T. Fischer, and R. Riedl, “New perspectives in oral peptide delivery,” Drug Discovery Today, vol. 26, no. 4, pp. 1097–1105, Jan. 2021, doi: 10.1016/j.drudis.2021.01.020.
ZIZZARI, Alessandra Tania, Dimanthi PLIATSIKA, Flavio GALL, Thomas FISCHER und Rainer RIEDL, 2021. New perspectives in oral peptide delivery. Drug Discovery Today. 23 Januar 2021. Bd. 26, Nr. 4, S. 1097–1105. DOI 10.1016/j.drudis.2021.01.020
Zizzari, Alessandra Tania, Dimanthi Pliatsika, Flavio Gall, Thomas Fischer, and Rainer Riedl. 2021. “New Perspectives in Oral Peptide Delivery.” Drug Discovery Today 26 (4): 1097–1105. https://doi.org/10.1016/j.drudis.2021.01.020.
Zizzari, Alessandra Tania, et al. “New Perspectives in Oral Peptide Delivery.” Drug Discovery Today, vol. 26, no. 4, Jan. 2021, pp. 1097–105, https://doi.org/10.1016/j.drudis.2021.01.020.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.